MULTIPLE-DOSE PHARMACOKINETICS AND TOLERATION OF INTRAVENOUSLY ADMINISTERED CEFOPERAZONE AND SULBACTAM WHEN GIVEN AS SINGLE AGENTS OR IN COMBINATION

被引:24
作者
REITBERG, DP
WHALL, TJ
CHUNG, M
BLICKENS, D
SWARZ, H
ARNOLD, J
机构
[1] QUINCY RES CTR,KANSAS CITY,MO 64127
[2] PFIZER INC,DIV QUAL CONTROL,GROTON,CT 06340
关键词
D O I
10.1128/AAC.32.1.42
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:42 / 46
页数:5
相关论文
共 16 条
[1]  
BALANT L, 1980, CLIN THER, V3, P50
[2]   PHARMACOKINETICS OF CEFOPERAZONE IN NORMAL VOLUNTEERS AND SUBJECTS WITH RENAL-INSUFFICIENCY [J].
BOLTON, WK ;
SCHELD, WM ;
SPYKER, DA ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (05) :821-825
[3]   COMPARATIVE PHARMACOKINETICS AND TISSUE PENETRATION OF SULBACTAM AND AMPICILLIN AFTER CONCURRENT INTRAVENOUS ADMINISTRATION [J].
BROWN, RM ;
WISE, R ;
ANDREWS, JM ;
HANCOX, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :565-567
[4]  
COHEN MS, 1984, AM J MED, V31, P34
[5]   PHARMACOKINETICS OF CEFOPERAZONE - A REVIEW [J].
CRAIG, WA ;
GERBER, AU .
DRUGS, 1981, 22 :35-45
[6]  
CRAIG WA, 1980, CLIN THER, V3, P46
[7]   CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].
ENGLISH, AR ;
RETSEMA, JA ;
GIRARD, AE ;
LYNCH, JE ;
BARTH, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419
[8]   PHARMACOKINETICS OF SULBACTAM IN HUMANS [J].
FOULDS, G ;
STANKEWICH, JP ;
MARSHALL, DC ;
OBRIEN, MM ;
HAYES, SL ;
WEIDLER, DJ ;
MCMAHON, FG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :692-699
[9]  
GREENFIELD RA, 1983, REV INFECT DIS, V5, pS127
[10]   INVITRO ANTIMICROBIAL SPECTRUM, OCCURRENCE OF SYNERGY, AND RECOMMENDATIONS FOR DILUTION SUSCEPTIBILITY TESTING CONCENTRATIONS OF THE CEFOPERAZONE-SULBACTAM COMBINATION [J].
JONES, RN ;
BARRY, AL ;
PACKER, RR ;
GREGORY, WW ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1725-1729